A Phase 1, Open-Label, Multicenter Study of HMPL-306 in Advanced Acute Myeloid Leukemia with Isocitrate Dehydrogenase Mutations. // Clinical Lymphoma, Myeloma & Leukemia. – URL: https://www.sciencedirect.com/science/article/pii/S2152265026040097?dgcid=rss_sd_all
A Phase 1, Open-Label, Multicenter Study of HMPL-306 in Advanced Acute Myeloid Leukemia with Isocitrate Dehydrogenase Mutations. Clinical Lymphoma, Myeloma & Leukemia. https://www.sciencedirect.com/science/article/pii/S2152265026040097?dgcid=rss_sd_all
“A Phase 1, Open-Label, Multicenter Study of HMPL-306 in Advanced Acute Myeloid Leukemia with Isocitrate Dehydrogenase Mutations.” Clinical Lymphoma, Myeloma & Leukemia.
@article{article41224,
title = {A Phase 1, Open-Label, Multicenter Study of HMPL-306 in Advanced Acute Myeloid Leukemia with Isocitrate Dehydrogenase Mutations},
journal = {Clinical Lymphoma, Myeloma \& Leukemia},
url = {https://www.sciencedirect.com/science/article/pii/S2152265026040097?dgcid=rss_sd_all}
}